Accurate diagnosis is imperative. There have been four generations of immunoassays for HIV screening and diagnosis, and third- and fourth-generation tests offer very high performances ...

Austin, April 12, 2025 (GLOBE NEWSWIRE) -- According to a new report by SNS Insider, the Immunoassay Analyzers Market, valued at USD 7.55 billion in 2023, is projected to reach USD 10.16 billion ...

Chimera Biotec, founded in 2000 as a spin-off from academic research in Germany, has implemented its proprietary DNA-antibody conjugates within the highly innovative Imperacer product line ...